About Stanford University Medical Center, Division of Hematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Stanford University Medical Center, Division of Hematology
During the past decade, Stanford University Medical Center, Division of Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Stanford University Medical Center, Division of Hematology
According to Clinical.Site data, the most researched conditions in "Stanford University Medical Center, Division of Hematology" are
"Hemoglobinuria, Paroxysmal" (2 trials), "Multiple Myeloma" (1 trials), "Multiple Myeloma in Relapse" (1 trials), "Paroxysmal Hemoglobinuria, Nocturnal" (1 trials) and "Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Stanford University Medical Center, Division of Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Stanford University Medical Center, Division of Hematology
Most popular intervention types in "Stanford University Medical Center, Division of Hematology" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "eculizumab" (3 trials), "CC-5013" (1 trials), "Dexamethasone" (1 trials), "bortezomib" (1 trials) and "dexamethasone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stanford University Medical Center, Division of Hematology
The vast majority of trials in "Stanford University Medical Center, Division of Hematology" are
5 trials for "All" genders.
Clinical Trials Status at Stanford University Medical Center, Division of Hematology
Currently, there are NaN active trials in "Stanford University Medical Center, Division of Hematology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Stanford University Medical Center, Division of Hematology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stanford University Medical Center, Division of Hematology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".